drugset / Trial / NCT06071442

Potential Drug Interaction Study Between Vemircopan and Rosuvastatin, Metformin, Levonorgestrel/Ethinyl Estradiol-containing Oral Contraceptives, and Carbamazepine

NCT06071442

Phase 1 Completed 60 enrolled Alexion Pharmaceuticals, Inc.
Non-randomizedParallel-groupOpen-labelTreatment

Summary

This study will investigate the potential drug interactions between vemircopan and metformin, rosuvastatin, levonorgestrel/ ethinyl estradiol (LNG/EE)-containing oral contraceptive(s) (OCs), and carbamazepine in healthy participants.

Timeline

Start
2024-01-17
Primary completion
2024-04-12
Completion
2024-04-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Carbamazepine Small molecule Oral
Subject Levonorgestrel / Ethinyl Estradiol Unknown Oral
Subject Metformin Small molecule Oral
Subject Rosuvastatin Small molecule Oral
Subject Vemircopan Small molecule Oral

Indications

No indication recorded.